» Articles » PMID: 1705416

Hypoxia and Inflammatory Synovitis: Observations and Speculation

Overview
Journal Ann Rheum Dis
Specialty Rheumatology
Date 1991 Feb 1
PMID 1705416
Citations 46
Authors
Affiliations
Soon will be listed here.
Citing Articles

NF-κB and TET2 promote macrophage reprogramming in hypoxia that overrides the immunosuppressive effects of the tumor microenvironment.

de la Calle-Fabregat C, Calafell-Segura J, Gardet M, Dunsmore G, Mulder K, Ciudad L Sci Adv. 2024; 10(38):eadq5226.

PMID: 39292770 PMC: 11409945. DOI: 10.1126/sciadv.adq5226.


A DNA origami device spatially controls CD95 signalling to induce immune tolerance in rheumatoid arthritis.

Li L, Yin J, Ma W, Tang L, Zou J, Yang L Nat Mater. 2024; 23(7):993-1001.

PMID: 38594486 DOI: 10.1038/s41563-024-01865-5.


Using Cu-Based Metal-Organic Framework as a Comprehensive and Powerful Antioxidant Nanozyme for Efficient Osteoarthritis Treatment.

Yu B, Sun W, Lin J, Fan C, Wang C, Zhang Z Adv Sci (Weinh). 2024; 11(13):e2307798.

PMID: 38279574 PMC: 10987124. DOI: 10.1002/advs.202307798.


LKB1 Regulates Inflammation of Fibroblast-like Synoviocytes from Patients with Rheumatoid Arthritis via AMPK-Dependent SLC7A11-NOX4-ROS Signaling.

Lee H, Yoo S, Kim J, Kang S Cells. 2023; 12(9).

PMID: 37174663 PMC: 10177119. DOI: 10.3390/cells12091263.


pH-Responsive Charge-Conversion Progelator Peptides.

Carlini A, Choi W, McCallum N, Gianneschi N Adv Funct Mater. 2022; 31(13).

PMID: 36530181 PMC: 9757809. DOI: 10.1002/adfm.202007733.


References
1.
King S, Booyse F, Lin P, Traylor M, Narkates A, Oparil S . Hypoxia stimulates endothelial cell angiotensin-converting enzyme antigen synthesis. Am J Physiol. 1989; 256(6 Pt 1):C1231-8. DOI: 10.1152/ajpcell.1989.256.6.C1231. View

2.
Morris P, ELLIS M, Swain J . Angiogenic potency of nucleotide metabolites: potential role in ischemia-induced vascular growth. J Mol Cell Cardiol. 1989; 21(4):351-8. DOI: 10.1016/0022-2828(89)90645-7. View

3.
Braquet P, Koltai M, Bourgain R, Bussolino F, Hosford D . Is there a case for PAF antagonists in the treatment of ischemic states?. Trends Pharmacol Sci. 1989; 10(1):23-30. DOI: 10.1016/0165-6147(89)90103-x. View

4.
Lefer A . Platelet activating factor (PAF) and its role in cardiac injury. Prog Clin Biol Res. 1989; 301:53-60. View

5.
Tonnesen M . Neutrophil-endothelial cell interactions: mechanisms of neutrophil adherence to vascular endothelium. J Invest Dermatol. 1989; 93(2 Suppl):53S-58S. DOI: 10.1111/1523-1747.ep12581069. View